Clinical Trials Logo

Filter by:
NCT ID: NCT00139386 Completed - Hypertension Clinical Trials

Candesartan for Prevention of Cardiovascular Events After Cypher or Taxus Coronary Stenting (4C) Trial

Start date: October 2005
Phase: Phase 4
Study type: Interventional

Candesartan is effective in preventing cardiovascular events in patients without restenosis after coronary angioplasty. Therefore, the investigators hypothesized that candesartan after drug-eluting stent (DES) implantation was also effective in preventing cardiovascular events. The purpose of this study is to investigate whether an angiotensin II receptor blocker, candesartan, is effective in reducing the incidence of cardiovascular events after drug-eluting stent implantation.

NCT ID: NCT00138008 Completed - Prostate Cancer Clinical Trials

Trial to Evaluate Radiotherapy Followed by Endocrine Therapy Vs Endocrine Therapy Alone for PSA Failure After Radical Prostatectomy

Start date: May 2004
Phase: Phase 3
Study type: Interventional

The purpose of this study is to evaluate radiotherapy followed by endocrine therapy in comparison with endocrine therapy alone for PSA failure after radical prostatectomy.

NCT ID: NCT00137787 Completed - Febrile Neutropenia Clinical Trials

Comparing Ciprofloxacin (CPFX) With Cefepime (CFPM) in Febrile Neutropenic Patients With Hematologic Diseases

Start date: April 2005
Phase: Phase 3
Study type: Interventional

The aim of this study is to investigate whether intravenous ciprofloxacin is as effective as cefepime for the initial treatment of febrile neutropenia developed in patients with hematologic diseases.

NCT ID: NCT00135551 Completed - Clinical trials for Cardiovascular Disease

Benidipine-based Comparison of Angiotensin Receptors, β-blockers, or Thiazide Diuretics in Hypertensive Patients

COPE
Start date: May 2003
Phase: Phase 4
Study type: Interventional

A number of major clinical trials have demonstrated the clinical benefits of lowering blood pressure and have indicated that a majority of patients with hypertension will require more than one drug to achieve optimal blood pressure control. There is little data showing which antihypertensive combination best protects patients from cardiovascular events and which best achieves the target blood pressure with the fewest adverse events. The COPE trial is planned to investigate, in patients with hypertension, which combination of the antihypertensive drugs, angiotensin receptor blockers, β-blockers or thiazide diuretics in addition to a long-acting calcium antagonist, benidipine hydrochloride, is superior to achieve the targeted blood pressure and prevent cardiovascular events with the fewest adverse drug effects.

NCT ID: NCT00135512 Completed - Depressive Disorder Clinical Trials

Study Of 323U66 SR In Major Depressive Disorder

Start date: December 1, 2004
Phase: Phase 2
Study type: Interventional

This study was designed to evaluate the efficacy and safety in major depressive disorder patients.

NCT ID: NCT00134472 Completed - Clinical trials for Brain Injuries, Traumatic

Therapeutic Hypothermia for Severe Traumatic Brain Injury in Japan

Start date: December 2002
Phase: Phase 3
Study type: Interventional

The purpose of this trial is to determine if mild hypothermia therapy, for severe head trauma patients, improves neurological outcome.

NCT ID: NCT00134160 Completed - Hypertension Clinical Trials

OlmeSartan and Calcium Antagonists Randomized (OSCAR) Study

Start date: August 2005
Phase: Phase 4
Study type: Interventional

The purpose of this study is to investigate whether high-dose angiotensin II receptor blocker (ARB) monotherapy or combination therapy with ARB and calcium channel blockers is more effective in reducing the incidence of cardiovascular events in Japanese elderly high-risk hypertensive patients not adequately controlled by standard dose ARB alone.

NCT ID: NCT00132665 Completed - Clinical trials for Non-Small-Cell Lung Carcinoma

Trial to Evaluate Radiotherapy With or Without CBDCA in Elderly Patients With Non-Small Cell Lung Cancer (JCOG0301)

Start date: July 2003
Phase: Phase 3
Study type: Interventional

The purpose of this study is to evaluate whether radiotherapy with carboplatin will result in longer survival than radiotherapy alone in elderly patients with unresectable stage III NSCLC.

NCT ID: NCT00132639 Completed - Pulmonary Neoplasms Clinical Trials

Study of Preoperative Docetaxel or Cisplatin (CDDP) + Docetaxel for C-stage IB-II Non-Small Cell Lung Cancer (NSCLC)

Start date: October 2002
Phase: Phase 2
Study type: Interventional

The purpose of this study is to evaluate the safety and efficacy of the preoperative docetaxel and docetaxel-cisplatin combination in c-stage IB/II NSCLC, and select the optimal preoperative therapy for phase III trials.

NCT ID: NCT00132613 Completed - Clinical trials for Malignant Pericardial Effusion

Trial of Drainage With or Without Bleomycin Instillation for Malignant Pericardial Effusion

Start date: August 1999
Phase: Phase 3
Study type: Interventional

The purpose of this study is to evaluate the efficacy of pericardial instillation of bleomycin as a sclerosing agent after pericardial drainage for lung cancer-associated malignant pericardial effusion.